Literature DB >> 9443863

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

G Parmigiani1, D Berry, O Aguilar.   

Abstract

Breast cancer-susceptibility genes BRCA1 and BRCA2 have recently been identified on the human genome. Women who carry a mutation of one of these genes have a greatly increased chance of developing breast and ovarian cancer, and they usually develop the disease at a much younger age, compared with normal individuals. Women can be tested to see whether they are carriers. A woman who undergoes genetic counseling before testing can be told the probabilities that she is a carrier, given her family history. In this paper we develop a model for evaluating the probabilities that a woman is a carrier of a mutation of BRCA1 and BRCA2, on the basis of her family history of breast and ovarian cancer in first- and second-degree relatives. Of special importance are the relationships of the family members with cancer, the ages at onset of the diseases, and the ages of family members who do not have the diseases. This information can be elicited during genetic counseling and prior to genetic testing. The carrier probabilities are obtained from Bayes's rule, by use of family history as the evidence and by use of the mutation prevalences as the prior distribution. In addressing an individual's carrier probabilities, we incorporate uncertainty about some of the key inputs of the model, such as the age-specific incidence of diseases and the overall prevalence of mutations. There is some evidence that other, undiscovered genes may be important in explaining familial breast cancer. Users of the current version of the model should be aware of this limitation. The methodology that we describe can be extended to more than two genes, should data become available about other genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443863      PMCID: PMC1376797          DOI: 10.1086/301670

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Evaluation of likelihood ratios for complex genetic models.

Authors:  E A Thompson; S W Guo
Journal:  IMA J Math Appl Med Biol       Date:  1991

2.  Effect of age on incidence of breast cancer in females.

Authors:  S H Moolgavkar; R G Stevens; J A Lee
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

3.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

Authors:  D F Easton; L Steele; P Fields; W Ormiston; D Averill; P A Daly; R McManus; S L Neuhausen; D Ford; R Wooster; L A Cannon-Albright; M R Stratton; D E Goldgar
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

4.  Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

5.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

6.  A likelihood approach to calculating risk support intervals.

Authors:  S M Leal; J Ott
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

7.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

Review 9.  Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

Authors:  R Yancik
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  216 in total

1.  Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG).

Authors:  D M Eccles; D G Evans; J Mackay
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

Review 2.  Why should primary care physicians know about breast cancer genetics?

Authors:  L E Pinsky; J B Culver; J Hull; E Levy-Lahad; M Daly; W Burke
Journal:  West J Med       Date:  2001-09

3.  The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing.

Authors:  Alexandre Sibert; David E Goldgar
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

4.  Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.

Authors:  M de la Hoya; O Díez; P Pérez-Segura; J Godino; J M Fernández; J Sanz; C Alonso; M Baiget; E Díaz-Rubio; T Caldés
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

5.  BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect.

Authors:  Danièle Muller; Catherine Bonaiti-Pellié; Joseph Abecassis; Dominique Stoppa-Lyonnet; Jean-Pierre Fricker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

6.  A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Authors:  D G R Evans; D M Eccles; N Rahman; K Young; M Bulman; E Amir; A Shenton; A Howell; F Lalloo
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 7.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

8.  High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers.

Authors:  Banu Arun; Kristen J Vogel; Adriana Lopez; Mike Hernandez; Deann Atchley; Kristine R Broglio; Christopher I Amos; Funda Meric-Bernstam; Henry Kuerer; Gabriel N Hortobagyi; Constance T Albarracin
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-27

9.  Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Authors:  P A Fasching; A B Ekici; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; M Schneider; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

10.  Tailoring BRCAPRO to Asian-Americans.

Authors:  Sining Chen; Amanda L Blackford; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.